Healthcare AI Guy Weekly | 6/10

Subscribe | Advertise | AI Startup Database | Feature AI Jobs

Our Picks ✨

Highlights if you’ve only got 2 minutes…

1/

Omada IPO + AI plans

Omada Health made a strong Nasdaq debut, with shares jumping 21% on day one: another sign that the digital health / health AI IPO window is finally reopening. Following successful IPOs from both Hinge Health and Tempus AI, Omada’s IPO once again shows growing investor interest in tech-enabled healthcare. The 13-year-old company has served over a million members with virtual care programs for chronic conditions and has now raised $150M at a $1.28B valuation. Although not yet profitable, Omada is growing fast and betting big on AI. The company recently launched OmadaSpark, a generative AI agent that delivers real-time nutrition education and motivational coaching, working hand-in-hand with human care teams. It’s part of a broader push into “between-visit care” that uses AI to fill gaps in support and drive better outcomes. It’s a glimpse of what next-gen digital care could look like: scalable, AI-powered, and deeply personal. (link)

2/

OpenEvidence partners with JAMA

OpenEvidence just inked a major partnership with the JAMA Network, giving its AI-powered clinical search engine access to full-text content from 13 of the most trusted medical journals in the world. This builds on similar deals with NEJM and Elsevier and reinforces OpenEvidence’s strategy: deliver real-time, evidence-based medical answers directly to clinicians. Already used by over 350,000 doctors and 10,000 hospitals, the company is also now rumored to be raising again at a $3B valuation (just months after its $1B Series A led by Sequoia). With rapid adoption and a growing ad-supported business model, OpenEvidence is quickly cementing itself as a central player in the future of clinical AI. (link)(tweet)(linkedin)

3/

FDA launches agencywide AI tool

The FDA just launched “Elsa,” a generative AI tool designed to speed up clinical reviews, summarize safety data, and support internal workflows. Built in AWS GovCloud, Elsa is based on Anthropic’s Claude LLM and developed by Deloitte. Since 2020, Deloitte has been paid $13.8M to build the FDA’s internal document database, and in April was awarded a $14.7M contract to scale the tech agency-wide. Elsa originated as CDER-GPT, a pilot from the FDA’s Center for Drug Evaluation and Research. Its rollout comes under new Chief AI Officer Jeremy Walsh, appointed in May. While Commissioner Marty Makary signaled the launch as “ahead of schedule and under budget,” internal reports suggest Elsa may be overhyped, buggy, and lacking clear use guardrails. Still, Elsa signals a high-profile bet on AI across the agency and a sign of more adoption to come. (link)(tweet)(linkedin)

Tools & Partnerships 🔧

Latest on business, consumer, and clinical healthcare AI tools and partnerships…

TOOLS

• FDA approves the first-ever AI tool to predict breast cancer: Clarity Breast’s AI analyzes subtle image patterns to generate five-year risk scores without relying on family history or demographics. It works with standard 2D mammograms and will launch commercially later this year. (link)

• Stanford pilots ChatEHR to streamline clinical workflows with AI: The new tool allows clinicians to query EHRs using natural language to retrieve patient data, summarize charts, and handle administrative tasks. It’s currently being tested at Stanford Hospital. (link)

• CHAI opens first AI validation hub for healthcare algorithms: The Coalition for Health AI certified its first assurance provider, partnering with BeeKeeperAI, Mount Sinai, and Morehouse to validate models using diverse patient data. The effort begins with chronic heart failure algorithms and aims to standardize healthcare AI evaluation. (link)

• AI outperforms humans on emotional intelligence tests: In a study from the University of Geneva and University of Bern, six AI models—including GPT-4 and Gemini—scored 81% on EQ assessments, compared to 56% for humans. GPT-4 also generated new valid tests, suggesting deeper emotional reasoning capabilities. (link)

• Amperos launches Amanda, an AI agent for billing and collections: Backed by $4.2M in seed funding, Amanda is billed as a multimodal AI coworker that navigates payer portals, escalates denials, and integrates data from billing systems to streamline RCM workflows. (link)

• Abridge releases pediatric well visit note powered by ambient AI: The new template uses ambient listening and contextual reasoning to auto-generate structured notes during primary care visits, tailored for pediatrics. (link)

• Researchers unveil BioReason, a hybrid AI for biological data and reasoning: BioReason combines a DNA model with LLM reasoning to boost performance on biological tasks, showing a 15% gain on benchmark tests. (link)

• AI-designed drug shows early promise for lung disease: Insilico Medicine’s rentosertib, developed entirely using AI, showed potential in treating idiopathic pulmonary fibrosis in a small clinical trial, marking a step forward for AI-first drug pipelines. (link)

• ElevenLabs launches Conversational AI 2.0 with HIPAA-compliant features: The new release includes advanced turn-taking, multilingual detection, and enterprise-ready upgrades, targeting healthcare and other regulated industries. (link)

• Nourish launches AI tools for virtual nutrition care: The new suite includes AI-powered meal logging, clinician insights, and a scribe that automates session notes. The tools aim to improve patient engagement and cut provider documentation time by up to 75%. (link)

PARTNERSHIPS

• Viz.ai + Novartis: Viz.ai and Novartis are partnering to use AI for faster identification and treatment of breast and prostate cancer, aiming to reduce care delays. (link)

• Patterson Health Center + PayZen: The Kansas-based rural health system implemented PayZen’s AI billing platform, offering patients pre-service Care Cards and post-service payment plans. (link)

• Allina Health + SoundHound AI: Allina launched “Alli,” an AI voice agent built with SoundHound and Amelia, to manage routine tasks like appointment scheduling and patient inquiries. (link)

• McFarland Clinic + Nabla: McFarland Clinic expanded Nabla’s AI documentation assistant across 12 specialties, continuing its push to reduce clinician burden. (link)

• WellTheory + Sentara Health Plans: WellTheory landed its first payer deal with Sentara to deliver personalized autoimmune care and reduce specialty drug costs. (link)

• Stanford Health Care + Atropos Health: Stanford is expanding its partnership with Atropos to embed real-world evidence directly into clinical workflows using AI, supporting faster, evidence-based decisions at the point of care. (link)

• MIT Computational Biology Lab + Lumeris: MIT and Lumeris are collaborating to advance computational models that guide population health strategies for value-based care. (link)

• RamSoft + Therapixel: RamSoft is integrating Therapixel’s MammoScreen AI into its PowerServer and OmegaAI platforms to improve breast cancer detection and radiologist efficiency. (link)

Deal Desk 💸 

Spotlight on latest capital raises, M&A, and investments…

FUNDING

• Prepared, an New York-based provider of emergency response tools, raised $80M. General Catalyst led, joined by insiders a16z, First Round Capital and Radical Ventures. (link)

• Outcomes4Me, a Boston-based AI cancer care startup, raised $21M led by Salica Investments. (link)

• Aeon, a Swiss full-body scanning startup, raised €8.2M. Concentric led, joined by Calm/Storm Ventures, GoHub, Kadmos, EWOR, and Daniel Gutenberg. (link)

• ArcheHealth, a Birmingham, Ala.-based provider of operational performance improvement tools for hospitals, raised $6.7M in seed funding from LRVHealth, Martin Ventures, and Texas Health Resources. (link)

• Amperos Health, a New York-based provider of health-care billing and claims automation tools, raised $4.2M in seed funding from Uncork Capital, Neo, and Nebular. (link)

• AIATELLA, a Helsinki-based AI-powered medical imaging company, raised $2.3M in funding. Nordic Science Investments led the round and was joined by Specialist VC, Harjavalta Ventures, Business Finland, and angel investors. (link)

• Matterworks, AI for predictive biology, raised new Series A financing. The round was led by Lewis & Clark Partners and OMX Ventures, joined by others. (link)

MERGERS & ACQUISITIONS

• H1 + Veda: H1, the healthcare tech company, has acquired Veda Data Solutions to build out its provider data and automation solutions for payers. (link)

Other Relevant News 🔍

News, podcasts, blogs, tweets, resources, etc…

• CVS Health commits $20B to health-tech initiatives (link)

• Health systems adjust hiring plans in response to AI (link)

• Generative AI in healthcare faces major execution gaps (link)

• New assistant secretary for technology policy at HHS (link)

• Fierce Biotech unveils its 2025 “Fierce 15” list of top startups (link)

• Top 25 healthcare companies on the 2025 Fortune 500 (link)

AI Job Opportunities 💼 

Contact us to feature roles in our newsletter…

• Health AI Researcher at OpenAI, an LLM foundation model company

  $245 - $440K | San Francisco (link)

• Senior FP&A Analyst at SmarterDx, an AI-powered revenue integrity platform

  $145 - $175K | Remote (link)

• Founding Engineer at Autoblocks AI, an LLM proactive testing startup

  $NA | NYC (link)

• Founding GTM/Growth at Oncare, an AI clinical ops platform for cancer care

  $NA | Remote (link)

• AI Care Program Manager at Akido Labs, an AI assistant for providers

  $110 - $120K | Los Angeles (link)

Visuals of the Week 📸

Funny memes, cool pics, and interesting data from around the web…